Innovation with a Purpose: Leading the Way to Advance Respiratory Care

Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, will be featuring medical technology designed to improve patient outcomes and reduce healthcare costs at the American Association for Respiratory Care (AARC) Congress 2014, Dec. 9-12 in Las Vegas.

“At Teleflex, we are dedicated to solving unmet clinical needs and delivering positive outcomes for patients and clinicians,” said James Ferguson, President, Respiratory Division, Teleflex. “We have united trusted brands, products and technology to help clinicians lead the way to advance respiratory care. We look forward to sharing the value of choosing Teleflex as a preferred partner with the entire respiratory therapy community.”

At the meeting, Teleflex will showcase the Hudson RCI® Neptune® Heated Humidifier with ConchaSmart® Technology offering best-in-class features such as low water notification and an Auto Settings mode. This innovative humidification platform provides a simple, smart, practical solution to meet the unique needs of patients, while helping clinicians manage time and money.

The new ISO-Gard® Mask with ClearAir™ Technology will also be featured at the meeting. A recent study published in the Journal of PeriAnesthesia Nursing (JOPAN) reported occupational exposure to waste anesthetic gases (WAG) in the post-anesthesia care unit (PACU) may be higher than standards recommend. The study evaluated and demonstrated that perianesthesia nurses are exposed to significantly less WAG when patients wear the ISO-Gard® Mask with ClearAir™ Technology from Teleflex, compared to a standard cannula or face tent.1

The Softech® Plus ETCO2 Sampling Cannula will be showcased at the meeting. The American Society of Anesthesiologists (ASA) has developed standards for basic anesthetic monitoring and recommends patient monitoring of CO2 during moderate or deep sedation. The Softech® Plus Sampling Cannula uses a divided design to deliver oxygen from one nare and sample carbon dioxide from the other, permitting an undiluted end tidal gas sample.

Teleflex is a corporate partner of the AARC and will be hosting a Photo Challenge at the Teleflex booth #840, with proceeds benefiting the American Respiratory Care Foundation (ARCF) and the International Council for Respiratory Care, a charitable organization of the ARCF.

About Teleflex Incorporated

Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Wayne, PA, Teleflex employs approximately 11,500 people worldwide and serves healthcare providers in more than 150 countries. Additional information about Teleflex can be obtained from the company's website at teleflex.com.

Forward-Looking Statements

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.

Teleflex, Arrow, ClearAir, ConchaSmart, Hudson RCI, ISO-Gard, LMA, Neptune, Rusch and Softech are trademarks or registered trademarks of Teleflex Incorporated or its affiliates.© 2014 Teleflex Incorporated. All rights reserved. MC-000450

Reference:

1. McGlothlin JD, Moenning JE, Cole, SS. Evaluation and Control of Waste Anesthetic Gases in the Postanesthesia Care Unit. Journal of PeriAnesthesia Nursing Volume 29, Issue 4, Pages 298-312, August 2014.

This study was funded in part by a grant from Teleflex. A pre-market version of the ISO-Gard Mask was studied. The IRB study was not an outcome study to support an FDA submission.

Teleflex IncorporatedJake ElguiczeTreasurer and Vice President, Investor Relations610-948-2836jake.elguicze@teleflex.comwww.teleflex.com

Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Teleflex Charts.
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Teleflex Charts.